Keywords: sb, moves, lilly, actos, new, avandia, combination

SB moves in on Lilly's Actos with new Avandia combination approval

Article | 05 April 2000

Print This

SmithKline Beecham has won an important new license from the US Food andDrug Administration with the approval of its antidiabetic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in